Brief: Prostatype Genomics Q1 EBITDA Loss SEK 3.4 Mln
May 27 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q1 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION,
AND
AMORTIZATION) AMOUNTED TO -3 417 TSEK.
Source text for Eikon: ID:nWkr4mdh4G
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue